van der Reijden BA - Search Results

1

High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients.

Noordermeer SM, Sanders MA, Gilissen C, Tönnissen E, van der Heijden A, Döhner K, Bullinger L, Jansen JH, Valk PJ, van der Reijden BA. Noordermeer SM, et al. Among authors: van der reijden ba, van der heijden a. Blood. 2011 Nov 17;118(20):5613-21. doi: 10.1182/blood-2011-06-359182. Epub 2011 Sep 21. Blood. 2011. PMID: 21937695 Free article.

2

RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts.

van der Reijden BA, Lombardo M, Dauwerse HG, Giles RH, Mühlematter D, Bellomo MJ, Wessels HW, Beverstock GC, van Ommen GJ, Hagemeijer A, et al. van der Reijden BA, et al. Among authors: van ommen gj. Blood. 1995 Jul 1;86(1):277-82. Blood. 1995. PMID: 7795233 Free article.

3

A gene for a myosin peptide is disrupted by the inv(16)(p13q22) in acute nonlymphocytic leukemia M4Eo.

van der Reijden BA, Dauwerse JG, Wessels JW, Beverstock GC, Hagemeijer A, van Ommen GJ, Breuning MH. van der Reijden BA, et al. Among authors: van ommen gj. Blood. 1993 Nov 15;82(10):2948-52. Blood. 1993. PMID: 8219185 Free article.

4

Acute leukemias with structurally altered core binding factor subunits (t(8;21), inv(16), t(12;21)), 27-28 June 1997, Rotterdam, The Netherlands.

van der Reijden BA, Bloomfield CD, Touw IP, Jansen JH. van der Reijden BA, et al. Leukemia. 1997 Dec;11(12):2217-9. Leukemia. 1997. PMID: 9447846

5

Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood.

Gomez E, van der Poel SC, Jansen JH, van der Reijden BA, Lowenberg B. Gomez E, et al. Among authors: van der reijden ba, van der poel sc. Blood. 1998 Mar 15;91(6):2208-9. Blood. 1998. PMID: 9490710 Free article. No abstract available.

6

TRIADs: a new class of proteins with a novel cysteine-rich signature.

van der Reijden BA, Erpelinck-Verschueren CA, Löwenberg B, Jansen JH. van der Reijden BA, et al. Protein Sci. 1999 Jul;8(7):1557-61. doi: 10.1110/ps.8.7.1557. Protein Sci. 1999. PMID: 10422847 Free PMC article.

7

Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact.

Döhner K, Schlenk RF, van der Reijden BA, Döhner H. Döhner K, et al. Among authors: van der reijden ba. Leukemia. 2000 Jun;14(6):1154. doi: 10.1038/sj.leu.2401804. Leukemia. 2000. PMID: 10865983 No abstract available.

8

Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676).

de Vetten MP, Jansen JH, van der Reijden BA, Berger MS, Zijlmans JM, Löwenberg B. de Vetten MP, et al. Among authors: van der reijden ba. Br J Haematol. 2000 Oct;111(1):277-9. doi: 10.1046/j.1365-2141.2000.02402.x. Br J Haematol. 2000. PMID: 11091212 Free article.

9

Degradable dU-based DNA template as a standard in real-time PCR quantitation.

Pennings JL, Van De Locht LT, Jansen JH, Van der Reijden BA, De Witte T, Mensink EJ. Pennings JL, et al. Among authors: van de locht lt, van der reijden ba. Leukemia. 2001 Dec;15(12):1962-5. doi: 10.1038/sj.leu.2402290. Leukemia. 2001. PMID: 11753618

10

Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.

Van der Reijden BA, de Wit L, van der Poel S, Luiten EB, Lafage-Pochitaloff M, Dastugue N, Gabert J, Löwenberg B, Jansen JH. Van der Reijden BA, et al. Among authors: van der poel s. Hematol J. 2001;2(3):206-9. doi: 10.1038/sj.thj.6200103. Hematol J. 2001. PMID: 11920247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page